Pooled TB Testing Could Save NHS Millions and Accelerate Diagnosis, Study Suggests

**Lead**

A groundbreaking study has suggested that adopting a ‘pooled’ testing approach for tuberculosis (TB) could save the National Health Service (NHS) significant sums of money while simultaneously improving diagnosis rates across the United Kingdom. The research, which analysed data from multiple healthcare settings, indicates that combining samples from several patients into a single test batch — rather than testing each sample individually — could cut laboratory costs by a substantial margin without compromising accuracy. The findings have already sparked discussions among health policymakers and public health officials, who are now weighing the potential benefits of integrating pooled testing into the UK’s TB control strategy.

**Contexto**

Tuberculosis remains a persistent public health challenge in the UK, particularly in urban areas and among vulnerable populations such as the homeless, migrants, and those with weakened immune systems. According to the latest figures from the UK Health Security Agency, there were approximately 4,800 notified cases of TB in England in 2024, a number that has remained relatively stable over the past decade. However, diagnosis often relies on expensive molecular tests that require individual processing, placing a heavy burden on laboratory resources and budgets. The new study, conducted by researchers from several British universities and published in a peer-reviewed medical journal, examined the feasibility of pooling samples — a technique already used in some countries for screening diseases such as HIV and hepatitis. By testing multiple samples together, laboratories could reduce the number of tests performed, thereby lowering reagent costs, staff time, and equipment wear. The study modelled the impact on a typical NHS laboratory serving a high-TB-burden area and found that pooled testing could reduce overall testing costs by up to a third, while maintaining sensitivity and specificity within acceptable thresholds.

**Analise**

The implications of this research extend far beyond the laboratory. For the NHS, which is under constant pressure to deliver value for money, any cost-saving measure that does not compromise patient care is politically attractive. The UK government has repeatedly pledged to tackle health inequalities and improve early diagnosis of infectious diseases, and pooled TB testing aligns with both objectives. Faster diagnosis means patients can begin treatment sooner, reducing the risk of transmission and the need for more expensive hospitalisations. Moreover, the savings generated could be redirected to other areas of TB control, such as contact tracing, outreach programmes, and support for adherence to treatment. From a policy perspective, the study provides a clear evidence base for updating national guidelines. The National Institute for Health and Care Excellence (NICE) currently recommends individual testing for TB, but the pooled approach could be considered for low-prevalence settings or as a first-line screening tool in high-risk groups. However, implementation would require careful calibration: pooled testing is most effective when the prevalence of TB is low, as the chance of a positive result in any given batch is small. In high-prevalence settings, individual testing may still be necessary to avoid diluting samples and missing cases. The study’s authors have called for a pilot programme in selected NHS trusts to test the approach in real-world conditions before any nationwide rollout.

**Analise**

The political dimension of this issue is significant. The UK is currently grappling with a broader debate about the sustainability of the NHS, with waiting lists, staff shortages, and budget constraints dominating headlines. Any innovation that promises to reduce costs without harming outcomes is likely to receive cross-party support. Labour and Conservative MPs have both expressed interest in evidence-based reforms to public health services, and the pooled TB testing study could become a test case for a more systematic approach to diagnostic efficiency. Furthermore, the timing is opportune: the government is in the process of updating its TB Action Plan for England, which sets out targets for reducing incidence and improving outcomes. Incorporating pooled testing into that plan would signal a commitment to innovation and cost-effectiveness. However, there are potential obstacles. Laboratory staff would need retraining, and new protocols would have to be developed to ensure that pooled samples are correctly handled and that positive batches are promptly resolved with individual retesting. There is also the risk of public perception: patients might worry that pooled testing is less accurate or that their sample could be confused with others. Clear communication and robust quality assurance would be essential to maintain trust. Despite these challenges, the study has already generated interest from NHS England’s innovation arm, which is exploring ways to accelerate the adoption of proven technologies.

**Fontes**

The information in this article is based on the study published in a peer-reviewed medical journal (details available upon request), data from the UK Health Security Agency’s annual TB report, and statements from public health officials and policymakers as reported by reputable news outlets. No individuals have been named in this article to avoid reliance on unverified sources.